User profiles for E François

Edouard Francois

InterDigital
Verified email at interdigital.com
Cited by 3093

Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a …

…, JF Bosset, PL Etienne, E Rio, É François… - The Lancet …, 2021 - thelancet.com
Background Treatment of locally advanced rectal cancer with chemoradiotherapy, surgery,
and adjuvant chemotherapy controls local disease, but distant metastases remain common. …

Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients

…, JY Douillard, R Brunet, E Francois… - Journal of Clinical …, 2002 - ascopubs.org
PURPOSE: To evaluate the efficacy and safety of an oxaliplatin, fluorouracil (5-FU), and
folinic acid (FA) combination in patients with metastatic or advanced gastric cancer (M/AGC). …

[PDF][PDF] Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203

…, M Untereiner, B Leduc, É Francois… - Journal of clinical …, 2006 - researchgate.net
… Gérard A, Buyse M, Nordlinger B, et al: Preoperative radiotherapy as adjuvant treatment
in rectal cancer: Final results of a randomized study of the European Organization for …

Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2

…, PL Etienne, V Vendrely, E François… - Journal of clinical …, 2010 - ascopubs.org
Purpose Neoadjuvant chemoradiotherapy is considered a standard approach for T3-4 M0
rectal cancer. In this situation, we compared neoadjuvant radiotherapy plus capecitabine with …

Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer

…, PL Etienne, V Vendrely, E François… - Journal of clinical …, 2012 - ascopubs.org
Purpose The ACCORD 12 trial investigated the value of two different preoperative
chemoradiotherapy (CT-RT) regimens in T3-4 Nx M0 resectable rectal cancer. Clinical results are …

Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion …

…, F Morvan, C Louvet, T Guillot, E François… - Journal of Clinical …, 1997 - ascopubs.org
PURPOSE This multicenter study compared the therapeutic ratio of a monthly schedule of
low-dose leucovorin (LV) and fluorouracil (5-FU) bolus with a bimonthly schedule of high-dose …

EUS-guided pancreaticogastrostomy

E François, M Kahaleh, M Giovannini, C Matos… - Gastrointestinal …, 2002 - Elsevier
Background: The pain of chronic pancreatitis can be caused by pancreatic ductal
hypertension, and endoscopic drainage of the main pancreatic duct can provide relief. When …

Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a …

…, P Michel, C Llacer-Moscardo, E François… - The lancet …, 2014 - thelancet.com
Background Definitive chemoradiotherapy is a curative treatment option for oesophageal
carcinoma, especially in patients unsuitable for surgery. The PRODIGE5/ACCORD17 trial …

[PDF][PDF] Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER …

…, JP Gérard, C Lemanski, E François… - J Clin Oncol, 2012 - academia.edu
… John M, Pajak T, Flam M, et al: Dose escalation in chemoradiation for anal cancer: … Doci R,
Zucali R, La Monica G, et al: Primary chemoradiation therapy with fluorouracil and cisplatin for …

Motion segmentation and qualitative dynamic scene analysis from an image sequence

P Bouthemy, E François - International Journal of Computer Vision, 1993 - Springer
… Before explaining how the minimization of the energy function W with respect to e is
pursued, let us comment on how we tackle the problem of deciding what is the right number of …